 | • レポートコード：D0-MOR-AP0343 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、デジタル乳房トモシンセシス機器の世界市場について調査・分析した資料で、デジタル乳房トモシンセシス機器の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Digital Breast Tomosynthesis Equipment Market is expected to register a CAGR of 13.5% during the forecast period. Digital breast tomosynthesis is a high-resolution limited-angle tomography technique that creates a 3-dimensional picture of the breast using X-rays. It is a new technology that helps in the early detection of breast cancer.
Digital breast tomosynthesis is especially useful in examining dense breasts and can improve and increase the ability to find breast cancer. It reduces the rate of false-positive readings (a reading that identifies normal tissue as an abnormality) and also reduces the need for a biopsy. It can be performed for any woman, but it is especially beneficial for women who have dense breasts.
According to the American Cancer Society in 2019, approximately 1 in 8 women (13%) will be diagnosed with invasive breast cancer in their lifetime and 1 in 39 women (3%) will die from breast cancer in the United States. Moreover, more than 150,000 breast cancer survivors are living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III in the United States. Increasing the prevalence of breast cancer worldwide, growing awareness about the use of tomosynthesis and technological advancements for developing new innovative imaging products are the key driving factors in digital breast tomosynthesis equipment market.
Key Market Trends
2D/3D Combination Mammography Systems Segment is Expected to Hold a Major Market Share in the Digital Breast Tomosynthesis (DBT) Equipment Market
2D/3D Combination Mammography Systems segment holds a significant market share in the digital breast tomosynthesis equipment market and is anticipated to show a similar trend over the forecast period. Combined 2D/3D mammography systems are superior to 2D mammography alone in the diagnosis of breast cancer because as shown by a number of large studies. As per the American Society of Clinical Oncology (ASCO) clinical trial report, a large US study of 4,54,850 patients found that combined 2D/3D Combination screening-detected 5.5 cancers per 1,000 women, compared with 4.3 cancers for 2D screening alone, a 28% higher detection rate with combined 2D/3D mammography systems. According to World Health Organization (WHO), breast cancer is the most frequent type of cancer among women globally, approximately 2.1 million women suffer from breast cancer every year, and with the highest number of cancer-related deaths among women. In the year 2018, it was estimated that approximately 627,000 women died from breast cancer that is nearly 15% of all cancer deaths among women globally. Furthermore, rising awareness about the use of these systems and high detection rates are the key driving factors in the 2D/3D combination mammography systems segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global digital breast tomosynthesis (DBT) equipment market due to the high demand for innovative products, increasing adoption of screening, and the presence of trained healthcare professionals in this region. According to the National Breast Cancer Foundation, in the year 2019, 62% of breast cancer cases were diagnosed at a localized stage. Female breast cancer represents approximately 15.2% of all new cancer cases in the United States. Furthermore, technological advancements in the field of breast imaging, the presence of well-established healthcare infrastructure and increasing healthcare spending are also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Digital Breast Tomosynthesis Equipment Market is Consolidated competitive and consists of a few major players. Some of the prominent players operating in the digital breast tomosynthesis (DBT) Equipment market are Hologic, Inc, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, General Medical Merate SpA (IMS GIOTTO SPA), Planmed Oy, Analogic Corporation and Trivitron Healthcare.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Breast Cancer Worldwide
4.2.2 Technological Advancements in the Field of Breast Imaging
4.2.3 Rising Awareness About the Use of Digital Breast Tomosynthesis (DBT)
4.3 Market Restraints
4.3.1 High Costs of the Systems
4.3.2 Side Effects Associated with Radiation Exposure
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 2D/3D Combination Mammography Systems
5.1.2 Standalone 3D Mammography Systems
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Centers
5.2.3 Other End-users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Hologic, Inc
6.1.2 GE Healthcare
6.1.3 Fujifilm Holdings Corporation
6.1.4 Siemens Healthineers
6.1.5 General Medical Merate SpA (IMS GIOTTO SPA)
6.1.6 Planmed Oy
6.1.7 Analogic Corporation
6.1.8 Trivitron Healthcare
7 MARKET OPPORTUNITIES AND FUTURE TRENDS